Sharps Compliance (NASDAQ:SMED) Stock Rating Lowered by Zacks Investment Research

Sharps Compliance (NASDAQ:SMEDGet Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Wednesday, Zacks.com reports.

According to Zacks, “Headquartered in Houston, Texas, SHARPS COMPLIANCE is a leading provider of cost-effective disposal solutions for small quantity generators of medical waste. The Company’s flagship product, the Sharps Disposal by Mail System, is a cost-effective and easy-to-use solution to dispose of medical waste such as hypodermic needles, lancets and any other medical device or objects used to puncture or lacerate the skin. The Company also offers a number of products specifically designed for the home healthcare market. Sharps Compliance focuses on targeted growth markets such as the pharmaceutical, retail, healthcare, commercial, professional and hospitality markets, as well as serving a variety of additional markets. Sharps is a leading proponent and participant in the development of public awareness and solutions for the safe disposal of needles, syringes and other sharps in the community setting. “

Other equities research analysts also recently issued reports about the stock. StockNews.com assumed coverage on shares of Sharps Compliance in a report on Thursday, March 31st. They set a “hold” rating on the stock. Roth Capital downgraded shares of Sharps Compliance from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $12.00 to $7.00 in a report on Tuesday, April 5th. Finally, TheStreet downgraded shares of Sharps Compliance from a “b-” rating to a “c+” rating in a report on Friday, December 17th. One analyst has rated the stock with a sell rating and four have given a hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $12.88.

NASDAQ SMED opened at $4.83 on Wednesday. The company has a market cap of $92.96 million, a PE ratio of 6.75 and a beta of -0.22. Sharps Compliance has a 52 week low of $4.72 and a 52 week high of $18.67. The company has a quick ratio of 3.40, a current ratio of 3.85 and a debt-to-equity ratio of 0.06. The firm’s 50-day simple moving average is $5.86 and its two-hundred day simple moving average is $6.91.

Sharps Compliance (NASDAQ:SMEDGet Rating) last released its quarterly earnings data on Wednesday, January 26th. The industrial products company reported $0.07 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.08 by ($0.01). The business had revenue of $18.88 million for the quarter, compared to analysts’ expectations of $18.41 million. Sharps Compliance had a net margin of 15.91% and a return on equity of 19.50%. During the same period last year, the company earned $0.07 earnings per share. As a group, equities research analysts anticipate that Sharps Compliance will post 0.12 EPS for the current year.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Citigroup Inc. raised its stake in Sharps Compliance by 228.8% in the fourth quarter. Citigroup Inc. now owns 5,544 shares of the industrial products company’s stock valued at $40,000 after purchasing an additional 3,858 shares in the last quarter. Royal Bank of Canada raised its stake in Sharps Compliance by 552.0% in the third quarter. Royal Bank of Canada now owns 7,804 shares of the industrial products company’s stock valued at $65,000 after purchasing an additional 6,607 shares in the last quarter. California State Teachers Retirement System raised its stake in Sharps Compliance by 32.0% in the fourth quarter. California State Teachers Retirement System now owns 10,133 shares of the industrial products company’s stock valued at $72,000 after purchasing an additional 2,454 shares in the last quarter. HighVista Strategies LLC purchased a new stake in Sharps Compliance in the third quarter valued at approximately $92,000. Finally, Janney Montgomery Scott LLC purchased a new stake in Sharps Compliance in the third quarter valued at approximately $110,000. 54.72% of the stock is currently owned by institutional investors and hedge funds.

About Sharps Compliance (Get Rating)

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications.

Further Reading

Get a free copy of the Zacks research report on Sharps Compliance (SMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.